Antitumor agent-81 is a low-cytotoxicity P62-RNF168 agonist that promotes the interaction between P62 and RNF168; it induces RNF168-mediated reduction of H2A ubiquitination and impairs homologous recombination-mediated DNA repair; it also inhibits the growth of xenograft tumors in mice in a dose-dependent manner.